Sunesis Pharmaceuticals
| Region | Nordamerika |
| ISIN | US8673288747 |
| Sektor | Biotechnologie |
| Website | https://www.sunesis.com/ |
Sunesis is a clinical-stage biopharmaceutical company focused on the development and commercialization of new oncology therapeutics. With a passion to advance novel drugs, we are inspired to make a difference in cancer patients' lives.
| Titel | Autor | Datum |
|---|---|---|
|
Risikoarmes "Peak Play" mit Multibagger-Potenzial
|
sharedeals | vor über 4 Jahren |
| Titel | Datum |
|---|---|
| Bursa, RHB, Hong Leong Bank, Axiata, MISC, IOI Properties, TM, GenP, Kerjaya Prospek, Sime Darby Property, 7-Eleven Malaysia, AAX, Pestec... | vor 19 Tagen |
| MISC's 1Q net profit falls 7%, declares eight sen dividend | vor 19 Tagen |
| MISC could potentially pay out higher dividends starting 2025 - Maybank | vor ungefähr 3 Monaten |
| MISC tied to $312M HD Hyundai deal for 'world's largest' ethane carriers | vor ungefähr 3 Monaten |
| MISC secures long-term contracts for two ethane carriers from Thailand's PTT | vor ungefähr 4 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Suedzucker (1 Artikel) | |
| Stockholm IT Ventures AB (1 Artikel) | |
| Tahoe Resources (1 Artikel) | |
| Telit Communications (3 Artikel) | |
| Alle anzeigen | |